MRNA reports Friday, Nov 6, 2026, before the open. After the last 4 reports the stock moved −5.4%, −1.2%, +5.3%, +3.3% the next day.
MRNA is expected to report on Friday, Nov 6, 2026, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Jul 31, 2026 | -2.06 | -1.97 | −5.4% | −7.0% |
| Apr 30, 2026 | -3.88 | -3.40 | −1.2% | +5.7% |
| Feb 13, 2026 | -2.64 | -2.11 | +5.3% | +24.3% |
| Nov 6, 2025 | -2.16 | -0.51 | +3.3% | +13.4% |
| Aug 1, 2025 | -3.00 | -2.13 | −6.6% | −10.0% |
| May 1, 2025 | -3.11 | -2.52 | −5.3% | −15.7% |
| Feb 14, 2025 | -2.73 | -2.91 | +3.4% | +11.3% |
| Nov 7, 2024 | -1.94 | 0.03 | −3.0% | −18.7% |
Average move the next trading day over the last 8 reports: ±4.2% (3 of 8 up).
MRNA is in an uptrend, momentum soft. $245.81 is the level overhead; $225 the first support below.
MRNA at $228.44. Nearest resistance $245.81 (+7.6%). Nearest support $225.00 (−1.5%).
MRNA chart, levels and analysis · Latest analysis: Moderna (MRNA) stock analysis, October 16, 2026: Uptrend holds after a 7.8% slide from the peak · Earnings this week
MRNA is expected to report on Friday, Nov 6, 2026, before the open.
MRNA reports before the open, US Eastern time.
After its report on Jul 31, 2026, MRNA moved −5.4% the next trading day.
Over the last 8 reports, MRNA moved 4.2% on average the next trading day, up 3 times out of 8.